✦ LIBER ✦

Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin

✍ Scribed by Andriulli, Angelo; Di Marco, Vito; Margaglione, Maurizio; Ippolito, Antonio Massimo; Fattovich, Giovanna; Smedile, Antonina; Valvano, Maria Rosa; Calvaruso, Vincenza; Gioffreda, Domenica; Milella, Michele; Morisco, Filomena; Felder, Martina; Brancaccio, Giuseppina; Fasano, Massimo; Gatti, Pietro; Tundo, Paolo; Barone, Michele; Cozzolongo, Raffaele; Angelico, Mario; D’Andrea, Giovanna; Andriulli, Nicola; Abate, Maria Lorena; Mazzella, Giuseppe; Gaeta, Giovanni Battista; Craxi, Antonio; Santantonio, Teresa

Book ID: 120912632
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 700 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2013.07.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1086 A SUBSTANTIAL PROPORTION OF NAIVE H

1086 A SUBSTANTIAL PROPORTION OF NAIVE HCV-1 INFECTED PATIENTS WITH CHRONIC INFECTION MAY BENEFIT FROM CURRENT STANDARD THERAPY WITH PEG-INTERFERON AND RIBAVIRIN

✍ Andriulli, A.; Valvano, M.R.; Spirito, F.; Ippolito, A.; Iacobellis, A.; Bossa, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Estimates of HCV-1 Patients Attaining RV

Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin

✍ Andriulli, A.; Iacobellis, A.; Valvano, M. R.; Spirito, F.; Ippolito, A.; Bossa, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 572 KB

Identification of naïve HVC-4 patients w

Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms

✍ Boglione, Lucio; Cusato, Jessica; De Nicolò, Amedeo; Cariti, Giuseppe; Allegra, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 560 KB

Cost–utility analysis of different peg-i

Cost–utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naïve Chinese patients with chronic hepatitis C

✍ W.-A. LIN; Y.-H. TARN; S.-L. TANG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Comparison of two PEG-interferon alpha-2

Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 μg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis

✍ B. Meyer-Wyss; P. Rich; Hp Egger; B. Helbling; B. Müllhaupt; C. Rammert; J.-J. G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

W1016 Efficacy and Safety of Erythropoie

W1016 Efficacy and Safety of Erythropoietin-Alfa On NaïVe Patients with Chronic Hepatitis C and Genotype 1 Receiving Combination Therapy with Pegylated Interferon-Alfa 2b and Ribavirin

✍ Purcell, Dagmary; Toro, Doris H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 124 KB